Evaluation of myocardial viability with iodine-123-BMIPP in a canine model

Journal of Nuclear Medicine

Volumn 37, Issue 8, 1996, Pages 1403-1407

  Nohara, Ryuji ^a   Okuda, Kazumi ^a   Ogino, Motonari ^a   Hosokawa, Ryohei ^a   Tamaki, Nagara ^a   Konishi, Junji ^a   Fujibayashi, Yasuhisa ^a   Yonekura, Yoshiharu ^a   Fujita, Masatoshi ^a   Sasayama, Shigetake ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

iodine 123 BMIPP; lipid metabolism; myocardial viability

Indexed keywords

ADENOSINE TRIPHOSPHATE; IODINE 123;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DOG; ECHOCARDIOGRAPHY; FATTY ACID OXIDATION; GLUCOSE BLOOD LEVEL; GLYCOLYSIS; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LIPID METABOLISM; NONHUMAN; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORONARY CIRCULATION; DOGS; FATTY ACIDS; IODINE RADIOISOTOPES; IODOBENZENES; MICROSPHERES; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM;

EID: 10144232090     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. 11C-substrates in vitro and in vivo. Circulation 1976;39: 24-32.
2. 11C-labeled palmitate. Circulation 1980;61:242-255.
3. 11C-palmitate. Circulation 1982;65:731-738.
4. Fox KAA, Abendschein DR, Ambos HD, Sobel BE, Bergmann SR. Efflux of metabolized and nonmetabolized fatty acid from canine myocardium. Circ Res 1985;57:232-243.
5. Rosamond TL, Abendschein DR, Sobel BE, Bergmann SR, Fox KAA. Metabolic fate of radiolabeled palmitate in ischemic canine myocardium: implications for positron emission tomography. J Nucl Med 1987;28:1322-1329.
6. Van der Wall EE, Westera G, den Hollander W, Visser FC. External detection of regional myocardial metabolism with radioiodinated hexadecanoic acid in the dog heart. Eur J Nucl Med 1981;6:147-151.
7. Schon HR, Senekowitsch R, Berg D, et al. Measurement of myocardial fatty acid metabolism: kinetics of iodine-123 heptadecanoic acid in normal dog hearts. J Nucl Med 1986;27:1449-1455.
8. Van der Wall EE, Heidendal GAK, den Hollander W, Westera G, Roos JP. Iodine-123-labeled hexadecanoic acid in comparison with thallium-201 for myocardial imaging in coronary heart disease. Eur J Nucl Med 1980;5:401-405.
9. 123I-labeled heptadecanoic acid in patients with angina pectoris. Eur J Nucl Med 1981;6:391-396.
10. 123I-labeled hepladecanoic acid in patients with angina pectoris. Eur J Nucl Med 1981;6:383-389.
11. 131I-I-pIPPA utilization. Eur J Nucl Med 1986;12:S32-S33.
12. 123I-iodophenyl) pentadecanoic acid in heart muscle and noncardiac tissues. Eur J Nucl Med 1985;10:228-234.
13. Rellas JS, Corbett LR, Kurkarni P, et al. Iodine-123 phenylpentadecanoic acid: detection of acute myocardial infarction and injury in dogs using an iodinated fatty acid and single-photon emission tomography. Am J Cardiol 1983;52:1326-1332.
14. 123I-phenylpentadecanoic acid myocardial scintigraphy: usefulness in the identification of myocardial ischemia. Circulation 1986;74:1007-1015.
15. Knapp FF, Goodman MM, Callahan AP, Kirsch G. Radioiodinated 15-(p-Iodophenyl)-3, 3-dimethylpentadecanoic acid: a useful new agent to evaluate myocardial fatty acid uptake. J Nucl Med 1986;27:521-531.
16. Knapp FF, Ambrose KR, Goodman MM. New radioiodinated methyl-branched fatty acids for cardiac studies. Eur J Nucl Med 1986;12:S39-S44.
17. Okuda K, Nohara R, Fujita M, Tamaki N, Konishi J, Sasayama S. Technetium-99m pyrophosphate uptake as an indicator of myocardial injury without infarct. J Nucl Med 1994;35:1366-1370.
18. Hale SL, Alker KJ, Kloner RA. Evaluation of nonradioactive, colored microspheres for measurement of regional myocardial blood flow in dogs. Circulation 1988;78:428-434.
19. Sellevold OFM, Jynge P, Aarstad K. High-performance liquid chromatography: a rapid isocratic method for determination of creatine compounds & adenine nucleotides in myocardial tissue. Mol Cell Cardiol 1986;18:517-527.
20. Takeyama N, Yakagi D, Adachi K, Tanaka T. Measurement of free and esterified carnitine in tissue extracts by high-performance liquid chromatography. Anal Biochem 1986;158:346-354.
21. Dudczak R, Schmoliner R, Angelberger P, Knapp FF, Goodman MM. Structurally modified fatty acids: clinical potential as tracers of metabolism. Eur J Nucl Med 1986;12:S45-S48.
22. Ambrose KR, Owen BA, Goodman MM, Knapp FF. Evaluation of metabolism in rat hearts of two new radioiodonated 3-methyl-branched fatty acid myocardial imaging agents. Eur J Nucl Med 1987;12:486-491.
23. 123I-β-methyl-iodophenyl pentadecanoic acid (BMIPP): comparison of myocardial perfusion and fatty utilization in canine myocardial infarction (occlusion and reperfusion model). Eur J Nucl Med 1989;15:341-345.
24. 131I-iodophenyl)-β-methylpentadecanoic acid in normotensive and hypertensive rats. J Nucl Med 1986;27:1178-1183.
25. Yonekura Y, Brill AB, Som P. Quantitative autoradiographic measurements of regional myocardial substrate utilization in hypertensive rats. Science 1985;227:1494-1496.
26. Kurata C, Kobayashi A, Yamazaki N. Dual tracer autoradiographic study with thallium-201 and radioiodinated fatty acids in cardiomyopathic hamsters. J Nucl Med 1989;30:80-87.
27. Fujibayashi Y, Yonekura Y, Takemura Y, et al. Myocardial accumulation of iodinated β-methyl-branched fatty acid analogue, iodine-125-15-(p-iodophenyl)-3-(R,S)-methylpentadecanoic acid (BMIPP), in relation to ATP concentration. J Nucl Med 1990;31:1818-1822.
28. 123I-BMIPP: comparison with coronary normal dogs, those pretreated with Etomoxir and those with ischemia [Abstract]. J Nucl Cardiol 1995;2(suppl):S38.
29. Czermin J, Porenta G, Brunken R, et al. Regional blood flow, oxidative metabolism and glucose utilization in patients with recent myocardial infarction. Circulation 1993;88:884-895.
30. Dean EN, Shlafer M, Nicklas JM. The oxygen consumption paradox of "stunned myocardium" in dogs. Basic Res Cardiol 1990;85:120-131.
31. Hosokawa R, Nohara R, Okuda K, et al. Cardiac metabolism of I-123-β-methyl-p-iodophenyl pentadecanoic acid (I-123 BMIPP) in normal dogs and those treated with carnitine palmitoyl-transferare, inhibitor (Etomoxir): contribution of α- and β-oxidation [Abstract]. J Nucl Med 1995;36(suppl):137P.
32. Tamaki N, Kawamoto M, Yonekura Y, et al. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: assessment with emission tomography using an ionated branched fatty acids. J Nucl Med 1992;33:659-667.